Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-04

FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved an Original Application for Prochlorperazine Maleate from Bionpharma Inc., authorizing its marketing as a generic antiemetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCHLORPERAZINE MALEATE (prochlorperazine maleate)

Snippet

ORIG AP for PROCHLORPERAZINE MALEATE (PROCHLORPERAZINE MALEATE)